Following Easter weekend’s river overflow, East Lansing residents are preparing for the Red Cedar River to soon flood again.
Trevi Therapeutics shifts to late-stage biotech with Haduvio for IPF chronic cough. Click here to read my latest analysis of ...
Trevi Therapeutics, Inc. TRVI shares are trading higher after the company announced the pricing of its $150 million offering ...
Toray Composite Materials America Inc., a Toray Group company specializing in PAN-based carbon fiber and carbon-fiber prepreg ...
A NUMBER of local photographers have been recognised for their work at the recent Irish Photographic Federation (IPF) National Print and Projected Image Finals, in association with Epson Ireland.
This press release shall not constitute an offer to sell, or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which ...
Bodybuilding Bros on MSN
74-year-old Shelly Ann consistently trains and aims to get stronger with age
Most people start strength training in their 30’s or 40’s, but Shelly Ann decided to lift weights at 64. And, after almost a ...
Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients ...
The acquisition brings together the gold standard for continuous ambulatory cough monitoring and lung sound analysis ...
There seems to be a strong exposure-response relationship between nerandomilast and the preservation of FVC in patients with PPF and IPF.
In what shakes out to be the largest follow-on stock offering in biopharma history, Revolution Medicines Inc., an oncology company that was the subject of buyout rumors earlier this year, priced 10.56 ...
A protein called PIEZO1, which is linked to mechanical stress, may play a key role in driving pulmonary fibrosis, a study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results